Chapter 3 Market Overview
- Introduction to Nanoparticles
- Liposomes
- Quantum Dots
- Dendrimers
- Macromolecule Nanoparticles
- Brief History of Nanoparticles
- Nanoparticles in Biotechnology
- Nanoparticles in Drug Development
- Nanoparticles in Drug Delivery Systems
- Nanoparticles in Diagnostic Imaging
- Major Players in the Nanoparticle Drug Delivery Field
- Major Nanoparticle/Nanocrystal Drugs
- Market Dynamics
- Drivers
- Restraints
- Pestel Analysis
- Regulatory Landscape
- U.S.
- Europe
- India
- Emerging Technologies in Nanoparticles
- Gadolinium-Neutron Capture Therapy (Gd-Nct) for Glioblastoma Multiforme (Gbm) Treatment
- Ligand-Tethered Lipid Nanoparticles for Targeted Rna Delivery to Treat Liver Fibrosis
Chapter 4 Role of Nanotechnology in Covid-19 Vaccine Production
- Introduction
- Fight Against Novel Coronavirus
- Structure of Covid-19 and Penetration
- Challenges for Covid-19 Vaccines
- Components and Methods in the Design of Vaccines
- Antigen
- Adjuvant
- Nanoparticle/Nanocarrier
- Device
- Next-Generation Vaccines Enabled Through Advances in Nanotechnology
- Conclusion on Nanotechnology Use Against Covid-19
Chapter 5 Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Technology
- Technology Overview
- Liposomes
- Polymeric Micelles
- Dendrimers
- Others
Chapter 6 Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Application
- Biotechnology
- Drug Development and Formulation
- Drug Delivery Systems
- Diagnostic Imaging
Chapter 7 Structure of Nanoparticles
- Adoption of Nanoparticles in Applied Markets
- Liquid Crystals
- Liquid Carriers
- Liposomes
- Dendrimers
- Chitosan and Alginate
- Nanocrystals
- Quantum Dots
- Application of Nanoparticles to Drugs Delivered
Chapter 8 Production of Nanoparticles
- Methods of Nanoparticle Formation
- Self-Assembly Production
- Methods of Stabilization
- Methods of Drug Introduction
- Polymeric Nanoparticles
- Micelles
- Liposomes
- Gold and Silicon Nanoparticles
- Dendrimers
- Methods for Loading Biological Molecules into Nanoparticles
- Nanocrystal Drugs
- Problems With Large-Scale Nanoparticle Production
Chapter 9 Nanoparticles in Biotechnology
- Research and Development
- Stem Cell Research
- Cellular Repair
- Paramagnetic and Superparamagnetic Nanoparticles
- Biosensors and Quantum Dots
- Nanoparticle Research Collaborative Programs
Chapter 10 Nanoparticles in Drug Development and Formulation
- Bio Separations
- Rapid Drug Analysis
- Removal of Impurities and Toxins
- Using Nanoparticles to Incorporate Insoluble Drugs
- Gold and Silver Nanoparticles in Biomedicine
- DNA Nanoparticle Development of DNA-Specific Drugs
Chapter 11 Nanoparticles in Drug Delivery Systems
- Nanoparticles in Drug Delivery Applications
- Designing a Nanoparticle Drug Delivery System
- Nanoparticle Drug Stability
- Size Homogeneity of Nanoparticle Preparations
- Drug Loading of Nanoparticles
- Drug Release from Nanoparticles
- External Triggers for Releasing Drugs from Nanoparticles
- Binding/Incorporation of Biomolecules to Nanoparticles
- Nanoparticle Toxicity
- Large-Scale Manufacturing
- Methods of Administration of Nanoparticle Drugs
- Oral Administration
- Injection Administration
- Transdermal Patch
- Implantation Administration
- Inhalation Administration
- Nanoparticles Suitable for Drug Delivery Systems
- Lipid-Based Nanoparticles
- Micelle Nanoparticles
- Dendrimer Nanoparticles
- Polymeric Nanoparticles
- Metal-Based Nanoparticles
- Biological Macromolecule Nanoparticles
- Nanocrystals
- Nanoparticle Drug Delivery Systems Now Available
- Antibiotic Nanoparticles
- Anti-Tumor and Small Molecule Delivery by Nanoparticle
- Release of Anti-Cancer Drugs from Nanoparticles
- Biomacromolecules Delivered by Nanoparticles
- Nanoparticles Coating for Drug Delivery Systems
- Removal of Nanoparticles from the Body
Chapter 12 in-Vitro and in Vivo Diagnostic Imaging
- In Vitro Imaging
- Nanoparticles in Diagnostic Imaging
Chapter 13 Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Region
- Market Overview and Discussion
- North America
- Europe
- Asia-Pacific
- Rest of the World
- South America
- Middle East and Africa
Chapter 14 Competitive Landscape
- Nanoparticle Drug Delivery Systems and Products
- Major Players in Nanoparticle Drug Delivery Systems
- Company Pipelines for Nanoparticle Drug Delivery
- Drivers of Nanoparticle Products and Marketing
- Limiters of Nanoparticle Product Development and Marketing
Chapter 15 Patents, Licensing, Mergers and Acquisitions
- Recent Licensing Activity, Mergers, and Acquisition
- Recent Deals
- Nanoparticle Patents
Chapter 16 Company Profiles
- Bristol-Myers Squibb Co.
- Camurus Ab
- Ceramisphere Health Pty Ltd.
- Cytimmune Sciences
- Gilead Sciences Inc.
- GlaxoSmithKline plc
- Hoffmann-La Roche Inc.
- Merck & Co. Inc.
- Nanocarrier Co. Ltd.
- Novartis Ag
List of Tables
Summary Table A: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Application, Through 2028
Summary Table B: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Technology, Through 2028
Table 1: Description of Nanoparticles Used in Drug Delivery and Diagnostic Imaging
Table 2: Applications of Nanoparticles in Biotechnology
Table 3: Applications of Nanoparticles in Drug Development
Table 4: Applications of Nanoparticles in Drug Delivery Systems
Table 5: Nanoparticles Used in Drug Delivery Systems
Table 6: Nanoparticles Used for In Vivo Diagnostic Imaging
Table 7: Major Players in the Nanoparticle Drug Field
Table 8: Major Nanoparticle/Nanocrystal Drug, by Product and Company
Table 9: Description of Nanomaterial Properties and Associated Risks
Table 10: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Technology, Through 2028
Table 11: Global Market for Liposomes Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, Through 2028
Table 12: Patents Related to Polymeric Micelles and Their Drug Delivery Applications, 2022
Table 13: Global Market for Polymeric Micelles Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, Through 2028
Table 14: Global Market for Dendrimers Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, Through 2028
Table 15: Global Market for Other Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, Through 2028
Table 16: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Application, Through 2028
Table 17: Global Market for Nanoparticles in Biotechnology, by Region, Through 2028
Table 18: Global Market for Nanoparticles in Drug Development and Formulation, by Region, Through 2028
Table 19: Global Market for Nanoparticles in Drug Delivery Systems, by Region, Through 2028
Table 20: Global Market for Nanoparticles in Diagnostics, by Region, Through 2028
Table 21: Nanoparticles Structure and Properties
Table 22: Nanoparticles Systems Approved for Drug Delivery
Table 23: Sample of Drugs Delivered Through Liposome Nanotechnology
Table 24: Nanoparticles in Biotechnology Applications
Table 25: Nano Biosensor Technology Under Development
Table 26: ETPN Strategic Research and Innovation Agenda
Table 27: Nanoparticles in Drug Development Applications
Table 28: Monoclonal antibody (mAb) Drugs with Potential for Use in Nanoparticles Delivery Systems
Table 29: Solid Lipid Nanoparticles-Reformatted Drugs
Table 30: Nanoparticles in Drug Delivery Applications
Table 31: Standard Routes of Drug Administration
Table 32: Nanoparticle Transdermal Patch Products
Table 33: Type of Nanoparticles Supplied in Drug Delivery Systems
Table 34: Mechanism for Removal of Nanoparticles from the Body
Table 35: Nanoparticles Contrast Media Used for In Vivo Diagnostic Imaging
Table 36: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery, by Region, Through 2028
Table 37: North American Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, Through 2028
Table 38: European Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, Through 2028
Table 39: Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, Through 2028
Table 40: List of Marketed Products Used in Different Nanotechnology-based Techniques
Table 41: Major Players in Nanoparticle Drug Development and Formulation Market
Table 42: Company Pipeline for Cardiovascular Nanoparticle Drugs
Table 43: Company Pipeline for CNS Disease Nanoparticle Drugs
Table 44: Company Pipeline for GI Disease Nanoparticle Drugs
Table 45: Company Pipeline for Infectious Disease Nanoparticle Drugs
Table 46: Company Pipeline for Cancer Nanoparticle Drugs
Table 47: Company Pipeline for Ophthalmic Nanoparticle Drugs
Table 48: Company Pipeline for Autoimmune Disease Nanoparticle Drugs
Table 49: Global Nanotechnology Patents, by Country, 2020-2023
Table 50: Bristol-Myers Squibb Co.: Financials, 2020-2022
Table 51: Camurus: Financials, 2020-2022
Table 52: Camurus: Developments, 2020-2022
Table 53: Cytimmune Sciences: Developments, 2020-2022
Table 54: Gilead Sciences Inc.: Financials, 2020-2022
Table 55: Gilead Sciences Inc.: Developments, 2020-2022
Table 56: GlaxoSmithKline PLC: Financials, 2020-2022
Table 57: GlaxoSmithKline PLC: Developments, 2020-2022
Table 58: Hoffmann-La Roche Inc.: Financials, 2020-2022
Table 59: Merck & Co. Inc.: Financials, 2020-2022
Table 60: Merck & Co. Inc.: Developments, 2020-2022
Table 61: NanoCarrier Co., Ltd.: Financials, 2020-2022
Table 62: NanoCarrier Co., Ltd.: Developments, 2020-2022
Table 63: Novartis AG: Financials, 2020-2022
List of Figures
Summary Figure A: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Application, 2020-2028
Summary Figure B: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Technology, 2020-2028
Figure 1: PESTEL Analysis: Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems Market
Figure 2: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, 2020-2028
Figure 3: Global Market Shares for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, 2023
Figure 4: North American Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 5: North American Market Shares of Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, 2023
Figure 6: European Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 7: European Market Shares of Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, 2023
Figure 8: Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 9: Asia-Pacific Market Shares of Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, 2023
Figure 10: South American Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 11: Middle Eastern and African Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 12: Bristol-Myers Squibb Co.: Research and Development Expenses, 2020-2022
Figure 13: Bristol-Myers Squibb Co.: Revenue Share, by Region, 2021
Figure 14: Camurus: Research and Development Expenses, 2020-2022
Figure 15: Camurus: Revenue Share, by Region, 2022
Figure 16: Camurus: SWOT Analysis
Figure 17: Gilead Sciences Inc.: Research and Development Expenses, 2020-2022
Figure 18: Gilead Sciences Inc.: Revenue Share, by Product Sales, 2022
Figure 19: GlaxoSmithKline PLC: Research and Development Expenses, 2020-2022
Figure 20: GlaxoSmithKline PLC: Revenue Share, by Segment, 2021
Figure 21: GlaxoSmithKline PLC: SWOT Analysis
Figure 22: Hoffman-La Roche Inc.: Research and Development Expenses, 2020-2022
Figure 23: Hoffman-La Roche Inc.: Revenue Share, by Segment, 2022
Figure 24: Merck & Co. Inc.: Research and Development Expenses, 2020-2022
Figure 25: Merck & Co. Inc.: Revenue Share, by Segment, 2022
Figure 26: Merck & Co. Inc.: SWOT Analysis
Figure 27: NanoCarrier Co., Ltd.: Net Assets, 2020-2022
Figure 28: Novartis AG: Operating Income, 2020-2022
Figure 29: Novartis AG: Revenue Share, by Segment, 2022
Figure 30: Novartis AG: SWOT Analysis
